GlassScriptPhysician profile
Jose E Collado Peralta
NPI 1205114360
$2,300.06
in general payments reported to CMS, 2019-2025
23 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $140 · 2021: $476 · 2022: $433 · 2023: $334 · 2024: $458 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $339.69 | 2019-2024 | |
| Abbott Laboratories | $289.97 | 2019-2025 | Cardiomems |
| Cvrx, INC. | $264.79 | 2023-2025 | Barostim Neo System |
| Abiomed | $216.58 | 2021-2024 | Impella |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.70 | 2021-2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $144.18 | 2019-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $99.00 | 2022 | |
| Medtronic, INC. | $77.80 | 2022-2023 | Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $77.11 | 2019-2020 | |
| Pfizer INC. | $67.83 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $60.69 | 2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $45.47 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $35.74 | 2022 | |
| Boston Scientific Corporation | $35.41 | 2024 | Watchman Flx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $31.73 | 2024 | |
| Intuitive Surgical, INC. | $29.61 | 2023 | Da Vinci Surgical System |
| Bayer Healthcare Pharmaceuticals INC. | $26.74 | 2022 | |
| Merck Sharp & Dohme LLC | $24.81 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $21.72 | 2023 | |
| Sanofi-Aventis U.S. LLC | $21.17 | 2019 | |
| Amgen INC. | $20.31 | 2020 | |
| Amarin Pharma, INC. | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Collado Peralta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.